GlassScriptPhysician profile
Alison Stewart
NPI 1407903925
$4,118.43
in general payments reported to CMS, 2019-2025
35 companies · $538 in 2025
The $538 reported for 2025 was more than what 77% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $417 · 2021: $607 · 2022: $928 · 2023: $740 · 2024: $699 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,950 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,950.13 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.50 | 2019-2024 | Orilissa, Lo Loestrin Fe, Liletta |
| Sumitomo Pharma America, INC. | $370.38 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $326.03 | 2022-2025 | |
| Exeltis, USA INC. | $315.53 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $295.00 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $273.42 | 2019-2025 | |
| Mylan Pharmaceuticals INC. | $262.38 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $207.23 | 2020-2025 | |
| Organon LLC | $170.09 | 2021-2025 | Nexplanon, Jada System |
| Avion Pharmaceuticals | $139.35 | 2020-2023 | Balcoltra |
| Millicent US INC | $137.99 | 2020-2025 | Femring, Intrarosa, Femlyv |
| Therapeuticsmd, INC. | $111.30 | 2019-2022 | |
| Amgen INC. | $107.51 | 2019-2024 | Prolia, Evenity |
| Merck Sharp & Dohme LLC | $107.31 | 2020-2022 | |
| Biom'Up France Sas | $93.61 | 2020-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $83.25 | 2022 | |
| Myovant Sciences INC. | $76.75 | 2021-2022 | |
| Hologic Sales and Service, LLC | $73.05 | 2022-2025 | Aptima |
| Evofem Biosciences, INC. | $57.27 | 2021-2025 | Solosec, Phexx, Phexxi |
| Coopersurgical, INC. | $53.60 | 2019-2025 | Paragard T 380a |
| Davol INC. | $38.34 | 2022 | |
| Scynexis, INC. | $37.43 | 2022 | |
| Stryker Corporation | $32.08 | 2023 | 1788 |
| Mycovia Pharmaceuticals, INC. | $24.68 | 2023 | Vivjoa |
| Meditrina | $22.62 | 2025 | |
| Roche Diagnostics Corporation | $20.33 | 2019 | |
| Agile Therapeutics, INC. | $20.15 | 2021 | |
| Convatec INC. | $19.07 | 2022 | |
| Exact Sciences Corporation | $18.35 | 2023 | Cologuard Collection Kit |
| Becton, Dickinson and Company | $17.98 | 2024 | Bd Onclarity |
| Coloplast Corp | $17.21 | 2023 | Altis |
| Duchesnay USA Incorporated | $15.16 | 2019 | |
| Ibsa Pharma INC. | $14.08 | 2023 | Tirosint, Licart |
| Teva Pharmaceuticals USA, INC. | $12.76 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.